227 related articles for article (PubMed ID: 32796926)
1. Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase.
Song K; Dai L; Long X; Wang W; Di W
Sci Rep; 2020 Aug; 10(1):13834. PubMed ID: 32796926
[TBL] [Abstract][Full Text] [Related]
2. Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation.
Dai L; Wang C; Song K; Wang W; Di W
J Ovarian Res; 2021 May; 14(1):62. PubMed ID: 33931106
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase (SphK) 1 and SphK2 play equivalent roles in mediating insulin's mitogenic action.
Dai L; Qi Y; Chen J; Kaczorowski D; Di W; Wang W; Xia P
Mol Endocrinol; 2014 Feb; 28(2):197-207. PubMed ID: 24422628
[TBL] [Abstract][Full Text] [Related]
4. Desmocollin 3 mediates follicle stimulating hormone-induced ovarian epithelial cancer cell proliferation by activating the EGFR/Akt signaling pathway.
Yang X; Wang J; Li WP; Jin ZJ; Liu XJ
Int J Clin Exp Pathol; 2015; 8(6):6716-23. PubMed ID: 26261554
[TBL] [Abstract][Full Text] [Related]
5. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
[TBL] [Abstract][Full Text] [Related]
6. Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype.
Perez-Juarez CE; Arechavaleta-Velasco F; Mendez C; Díaz-Cueto L
Med Oncol; 2020 May; 37(7):59. PubMed ID: 32474861
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation].
Sheng L; Liu DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):752-5. PubMed ID: 14728848
[TBL] [Abstract][Full Text] [Related]
8. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
Xu CL; Lu XL; Yan XN; Wang HL; Chen SQ
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):134-8. PubMed ID: 22455747
[TBL] [Abstract][Full Text] [Related]
9. A 50-Hz magnetic-field exposure promotes human amniotic cells proliferation via SphK-S1P-S1PR cascade mediated ERK signaling pathway.
Chen L; Xia Y; Lu J; Xie Q; Ye A; Sun W
Ecotoxicol Environ Saf; 2020 May; 194():110407. PubMed ID: 32146198
[TBL] [Abstract][Full Text] [Related]
10. Follicle-stimulating hormone promotes nerve growth factor and vascular endothelial growth factor expression in epithelial ovarian cells.
Garrido MP; Bruneau N; Vega M; Selman A; Tapia JC; Romero C
Histol Histopathol; 2020 Sep; 35(9):961-971. PubMed ID: 32369181
[TBL] [Abstract][Full Text] [Related]
11. The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.
Heublein S; Mayr D; Vrekoussis T; Friese K; Hofmann SS; Jeschke U; Lenhard M
PLoS One; 2013; 8(8):e71791. PubMed ID: 23951246
[TBL] [Abstract][Full Text] [Related]
12. OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer.
Liu L; Zhang J; Fang C; Zhang Z; Feng Y; Xi X
Biochem Biophys Res Commun; 2015 Jun; 461(3):525-32. PubMed ID: 25911324
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis.
Dai L; Liu Y; Xie L; Wu X; Qiu L; Di W
Oncotarget; 2017 Sep; 8(43):74947-74961. PubMed ID: 29088837
[TBL] [Abstract][Full Text] [Related]
14. SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.
Hart PC; Chiyoda T; Liu X; Weigert M; Curtis M; Chiang CY; Loth R; Lastra R; McGregor SM; Locasale JW; Lengyel E; Romero IL
Mol Cancer Res; 2019 Apr; 17(4):870-881. PubMed ID: 30655321
[TBL] [Abstract][Full Text] [Related]
15. Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.
Chen J; Bai M; Ning C; Xie B; Zhang J; Liao H; Xiong J; Tao X; Yan D; Xi X; Chen X; Yu Y; Bast RC; Zhang Z; Feng Y; Zheng W
Oncogene; 2016 May; 35(19):2506-17. PubMed ID: 26364616
[TBL] [Abstract][Full Text] [Related]
16. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
Zhang N; Qiu J; Zheng T; Zhang X; Hua K; Zhang Y
Oncol Rep; 2018 Mar; 39(3):1034-1042. PubMed ID: 29286125
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.
Beach JA; Aspuria PJ; Cheon DJ; Lawrenson K; Agadjanian H; Walsh CS; Karlan BY; Orsulic S
Oncotarget; 2016 Jan; 7(4):4167-82. PubMed ID: 26716409
[TBL] [Abstract][Full Text] [Related]
18. Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation.
Dai L; Wang C; Wang W; Song K; Ye T; Zhu J; Di W
Open Med (Wars); 2022; 17(1):229-238. PubMed ID: 35178477
[TBL] [Abstract][Full Text] [Related]
19. Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.
Zhang Z; Zhu Y; Lai Y; Wu X; Feng Z; Yu Y; Bast RC; Wan X; Xi X; Feng Y
Int J Oncol; 2013 Oct; 43(4):1194-204. PubMed ID: 23921511
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase.
Zhang H; Li W; Sun S; Yu S; Zhang M; Zou F
Cell Prolif; 2012 Apr; 45(2):167-75. PubMed ID: 22288844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
